barr 250mg 589 (Didanosine 250 mg)
Pill imprint barr 250mg 589 has been identified as Didanosine 250 mg.
Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for barr 250mg 589
- 250 mg
- Blue & White
- 23.00 mm
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
D&C Red No. 28
|NDC Code||Manufacturer / Repackager|
|62584-0046||Amerisource Health Services|
|68084-0431||Amerisource Health Services|
|13411-0192||Advanced Pharmaceutical Services Inc (repackager)|
|54868-5464||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about didanosine
- Didanosine chewable/dispersible buffered tablets
- Didanosine delayed-release enteric-coated capsules
- Didanosine powder pack
- Didanosine solution
- Didanosine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.